XML 36 R22.htm IDEA: XBRL DOCUMENT v3.19.1
Stock Options
12 Months Ended
Dec. 31, 2018
Share-based Payment Arrangement [Abstract]  
Stock Options

16. STOCK OPTIONS.

 

The Company adopted a stock option plan (“Plan”). The purpose of this Plan is to provide additional incentives to key employees, officers, directors and consultants of the Company and its subsidiaries in order to help attract and retain the best available personnel for positions of responsibility and otherwise promote the success of the Company’s business. It is intended that options issued under this Plan constitute non-qualified stock options. The general terms of awards under the option plan are that 100% of the options granted will vest the year following the grant. The maximum term of options granted is 5 years.

 

The Company may issue stock options and stock bonuses for shares of its common stock to provide incentives to directors, key employees and other persons who contribute to the success of the Company. The exercise price of all incentive options are issued for not less than fair market value at the date of grant.

 

The following table summarizes the Company’s stock option activity for the years ended December 31, 2018 and 2017:

 

    Number of shares     Exercise price
per share
    Weighted average exercise price  
Balance, December 31, 2016     813,000     $ 0.75 - $2.22     $ 1.19  
Granted     154,000     $ 1.70     $ 1.70  
Cancelled or expired     (114,000 )   $ 1.00 – 2.22     $ 1.75  
Exercised     (140,000 )   $ 0.75 – 1.21     $ 1.11  
Balance, December 31, 2017     713,000     $ 0.75 – 1.70     $ 1.21  
Granted     110,000     $ 1.48 – 1.75     $ 1.74  
Cancelled or expired     (61,334 )   $ 1.00 – 1.70     $ 1.09  
Exercised     (101,666 )   $ 0.75 – 1.42     $ 1.01  
Balance, December 31, 2018     660,000     $ 0.75 – 1.75     $ 1.35  
Exercisable, December 31, 2018     555,000     $ 0.75 – 1.70     $ 1.27  

 

The weighted-average remaining contractual life of outstanding options is 3.04 years.

 

The fair value of each option grant is calculated using the following weighted average assumptions:

 

    2018     2017  
Expected life – years     3.0       3.0  
Interest rate     2.8 – 2.96 %     2.23 %
Volatility     47.77 – 51.85 %     73.09 %
Dividend yield     %     %
Weighted average fair value of options granted   $ 0.4759 – 0.6313     $ 0.8344  

 

During the year ended December 31, 2018, the Company granted 100,000 (2017 – 40,000) stock options to consultants and has applied ASC 718 using the Black-Scholes option-pricing model, which resulted in additional expenses of $5,747 (2017 - $6,675). Options granted in other years resulted in additional expenses of $26,701 (2017 – $22,634). During the year ended December 31, 2018, employees were granted 10,000 (2017 – 114,000) stock options, which resulted in additional expenses of $5,150 (2017 – $19,024). Options granted in other years resulted in additional expenses in the amount of $73,594 for employees during the year ended December 31, 2018 (2017 - $67,759). There were 60,000 employee and 41,666 consultant stock options exercised during the year ended December 31, 2018 (2017 – 110,000 employee; 30,000 consultant).

 

As of December 31, 2018, there was approximately $57,383 of compensation expense related to non-vested awards. This expense is expected to be recognized over a weighted average period of 4.75 years.

 

The aggregate intrinsic value of vested options outstanding at December 31, 2018 is $43,190 (2017 – $413,410).